News | July 06, 2022
Regeneron completes purchase of Sanofi's stake in Libtayo
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
The company has received 2 observations on FDA Form 483 with respect to ANDA filed for the product to be manufactured at Indore plant.
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
Prior to this, Maria held multiple roles at Novartis including Head of Global Manufacturing Functions, and Global Head of Manufacturing, Science & Technology
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
The settlement and dismissal resolves all claims between the parties
Subscribe To Our Newsletter & Stay Updated
